Literature DB >> 18219499

[Current diagnosis and treatment of migraine].

H-C Diener1, Z Katsarava, V Limmroth.   

Abstract

Headaches are one of the most common disorders and symptoms in daily medical practice. The prevalence of migraine is 8% in men and 12-15% in women. Dramatic progress in the areas of epidemiology, pathophysiology, and acute and preventive therapy of migraine has been made over the past 100 years, with triptans being the breakthrough for treating acute migraine attacks. Beta blockers, calcium antagonists, and neuromodulators are available for preventive migraine therapy. Nonpharmacologic treatment also plays an important role in migraine prevention. New medical care structures such as integrated headache care provide better support for patients with migraine, particularly those with chronic migraine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18219499     DOI: 10.1007/s00482-007-0619-3

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  64 in total

1.  Perfusion weighted imaging during migraine: spontaneous visual aura and headache.

Authors:  M Sanchez del Rio; D Bakker; O Wu; R Agosti; D D Mitsikostas; L Ostergaard; W A Wells; B R Rosen; G Sorensen; M A Moskowitz; F M Cutrer
Journal:  Cephalalgia       Date:  1999-10       Impact factor: 6.292

2.  Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study.

Authors:  E A MacGregor; A Frith; J Ellis; L Aspinall; A Hackshaw
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

3.  The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study.

Authors:  H C Diener; V Pfaffenrath; L Pageler; H Peil; B Aicher
Journal:  Cephalalgia       Date:  2005-10       Impact factor: 6.292

4.  Obesity is a risk factor for transformed migraine but not chronic tension-type headache.

Authors:  Marcelo E Bigal; Richard B Lipton
Journal:  Neurology       Date:  2006-07-25       Impact factor: 9.910

Review 5.  Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society.

Authors:  D Lewis; S Ashwal; A Hershey; D Hirtz; M Yonker; S Silberstein
Journal:  Neurology       Date:  2004-12-28       Impact factor: 9.910

6.  Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.

Authors:  Hans-Christoph Diener
Journal:  Curr Med Res Opin       Date:  2005-10       Impact factor: 2.580

7.  Topiramate in the treatment of chronic migraine.

Authors:  M Silvestrini; M Bartolini; M Coccia; R Baruffaldi; R Taffi; L Provinciali
Journal:  Cephalalgia       Date:  2003-10       Impact factor: 6.292

Review 8.  Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine.

Authors:  David Dodick; Richard B Lipton; Vincent Martin; Vasilios Papademetriou; Wayne Rosamond; Antoinette MaassenVanDenBrink; Hassan Loutfi; K Michael Welch; Peter J Goadsby; Steven Hahn; Susan Hutchinson; David Matchar; Stephen Silberstein; Timothy R Smith; R Allan Purdy; Jane Saiers
Journal:  Headache       Date:  2004-05       Impact factor: 5.887

9.  Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

Authors:  Jes Olesen; Hans-Christoph Diener; Ingo W Husstedt; Peter J Goadsby; David Hall; Ulrich Meier; Stephane Pollentier; Lynna M Lesko
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

10.  Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.

Authors:  Sheena K Aurora; Marek Gawel; Jan L Brandes; Suriani Pokta; Amanda M Vandenburgh
Journal:  Headache       Date:  2007-04       Impact factor: 5.887

View more
  1 in total

Review 1.  NSAIDs in the Acute Treatment of Migraine: A Review of Clinical and Experimental Data.

Authors:  Arpad Pardutz; Jean Schoenen
Journal:  Pharmaceuticals (Basel)       Date:  2010-06-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.